Amanote Research
Register
Sign In
Bisphosphonates and Bone Metastases
British Journal of Cancer
- United Kingdom
doi 10.1038/bjc.1988.257
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
November 1, 1988
Authors
AR Morton
A Howell
Publisher
Springer Science and Business Media LLC
Related search
Concomitant Oral Tyrosine Kinase Inhibitors and Bisphosphonates in Advanced Renal Cell Carcinoma With Bone Metastases
British Journal of Cancer
Cancer Research
Oncology
Bisphosphonates Enhance Antitumor Effect of EGFR-TKIs in Patients With Advanced EGFR Mutant NSCLC and Bone Metastases
Scientific Reports
Multidisciplinary
Utilization of Bone Densitometry for Prediction and Administration of Bisphosphonates to Prevent Osteoporosis in Patients With Prostate Cancer Without Bone Metastases Receiving Antiandrogen Therapy
Cancer Management and Research
Oncology
Pcn162 - Denosumab Versus Bisphosphonates for the Treatment of Bone Metastases From Solid Tumors: A Systematic Review of Economic Studies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients With Non–Small Cell Lung Cancer and Bone Metastases: A Systematic Review
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Detection of Bone Metastases.
BMJ
Effect of Bisphosphonates on Bone Resorption and Prosta Glandin Synthesis
Ensho
Radioisotope Therapy of Bone Metastases
Nuclear Medicine Review
Medicine
Nuclear Medicine
Radiology
Imaging
Implications for Osteolytic Bone Metastases
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology